Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 4 Insider Changes in Ownership
  2. 8-K Event Regulation FD disclosure
  3. 8-K Event Regulation FD disclosure
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Executive or director change
  6. 10-Q Report Quarterly Report
  7. 8-K Event Executive or director change
  8. 8-K/A Event Exhibits
  9. 10-Q Report Quarterly Report
  10. NT 10-Q Other NT 10-Q
  11. 8-K Event Regulation FD disclosure
  12. EFFECT Other Notice of Effectiveness
  13. 424B3 Offering Prospectus
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. S-3/A Offering Registration Statement
  17. SC 13D Stake Beneficial Ownership Report
  18. 3 Insider Initial Statement of Ownership
  19. 4 Insider Changes in Ownership
  20. 3 Insider Initial Statement of Ownership

Page 12 of 31 · 604 filings